Jin Liqun, chairman of China Investment Corp.
Looking for health insurance? Find a variety of affordable medical insurance plans.
Facebook’s IPO is causing a frenzy among investors eager to get a piece of the social networking website.
Whether it’s a good idea to jump in when FB debuts Friday on the Nasdaq is another story.
"Investors shouldn’t invest in any one stock unless they can afford to lose it all," said Jay Ritter, professor of finance at the University of Florida. "With a growth company like Facebook, there is a lot of upside potential, but there is also substantial downside risk if the company fails to meet expectations."
Buying shares during the initial public offering process is particularly challenging for small investors. Shares of an IPO are primarily distributed to the institutional investors, mutual funds and hedge funds which are the biggest clients of the major Wall Street banks that are underwriting the offering.
While Facebook is making an effort to make some of its hotly sought after shares accessible to all, they’ll still be hard to come by.
The demand is so strong that Facebook raised the target price range for its stock to between $34 and $38 per share, from the $28 to $35 range it set earlier this month. And early Wednesday, Facebook said it will sell 25% more of its shares.
Sterne Agee analyst Arvind Bhatia says there’s a buying opportunity for investors if they’re able to snag Facebook shares within the IPO offering range. But to those who have to wait until Facebook shares begin trading on the open market on Friday, Bhatia urges caution.
Facebook IPO is no safe haven
Given all the hype, experts anticipate that the company will have a strong debut.
For example, when Groupon () went public last November, the stock opened at $28, 40% above its IPO price, and surged as much as 56% on its first day of trading when it hit an all-time high of $31.14.
If investors had purchased shares of Groupon during their first day of trading, they’ve likely had a tough time booking decent returns. The stock has been trading below its IPO price for months, and is currently 40% below its IPO price.
Similarly, Zynga () shares surged as much as 15% during their market debut in December, but ended up closing that day 5% below the IPO price. Shares are now trading more than 14% below the IPO price.
"I would say it’s better for individual investors to generally avoid playing the IPO game until a few quarters after the company goes public so that its stock is a bit more established," said Bhatia. "Or they need to be able to stomach a lot of volatility."
Seniors clamoring to invest in Facebook IPO
If you’re daring enough to try buying Facebook shares on opening day, there are a few ways to protect yourself.
For example, by using a so-called limit order, you can set a ceiling for the purchase price that you’ll be comfortable paying, said Tom Schrader, managing director at Stifel Nicolaus.
If the stock stays above your limit, or if other limit orders snatch up all the shares available at the limit price, the trade won’t be executed. You can also specify whether you want to consider buying the stock with the limit order just at the open or throughout the trading day.
On the flip side, if you nab some shares and want to sell them at a certain price, you can use a limit order that sets a floor on the sales price that you’re willing to accept, helping you prevent selling your shares for less than you want.
The hard part is determining what’s a fair price for a share of Facebook. Morningstar’s analyst Rick Summer pegs fair value for the stock at $32.
"The enthusiasm for Facebook is not misplaced, but the market may be underestimating near-term challenges for the company," he said.
How small investors can get in on Facebook IPO
In particular, Summer noted that while Facebook will be able to translate its immense user base - over 900 million a month — into massive growth over the long run, "the ability to further monetize current users represents a significant hurdle which must be overcome."
Concerns are particularly high about the company’s ability to monetize the growing number of users that are accessing Facebook on mobile devices.
"We see mobile monetization as a significant long-term growth opportunity for Facebook, but with some initial challenges," said Sterne Agee’s Bhatia, whose price target for Facebook’s stock over the next 12 months is $45. "For example, it is not yet clear if most of the mobile advertising growth will be incremental or will cannibalize online advertising."
Advertising accounted for 85% of Facebook’s total 2011 revenue, but to-date, most of Facebook’s ads have been display ads: banners, images and other graphics, ignoring mobile devices.
Another worry among analysts is Facebook CEO Mark Zuckerberg’s tight grip on the company. After the IPO, the young billionaire will control about 57% of the voting power.
Morningstar’s Summer notes that Facebook’s recent purchase of Instagram for $1 billion reportedly happened with little involvement from the company’s board of directors.
"If Mr. Zuckerberg loses discipline in allocating the company’s capital, there can be no guarantee that any such mechanism would prevent the company from destroying shareholder value," he said.
Following an IPO-induced pop, Summer said the focus on these looming challenges may lead to stock price declines and "ultimately create a very interesting buying opportunity for the shares at a later date."
Get up to $1500 with an fast cash loans in less than 1 hour - 100% online.
Japan
After a precipitous four-year plunge in its share price, Research In Motion Ltd. has tumbled from its perch as Canada
GlaxoSmithKline PLC has tabled an offer to take over U.S. drug maker Human Genome Sciences Inc. which values the target at nearly $2.6 billion.
GlaxoSmithKline, which has profit-sharing agreements with HGS on three drugs but a minimal shareholding, said Wednesday it is offering $13 cash per share for the company. A private offer last month by GSK at the same price was rejected by HGS management last month.
GSK said its offer was 81 percent more than the HGS share price on April 18, before HGS disclosed the earlier private offer. HGS shares closed at $14.39 Tuesday on the Nasdaq exchange.
The tender offer, which is a direct approach to the target’s shareholders, will remain open for 20 days. GSK said it hoped to complete the deal on a friendly basis.
GlaxoSmithKline shares were down 0.7 percent at 1,414 pence in early trading.
Human Genome Sciences, based in Rockville, Maryland, has a 50-50 profit sharing agreement with GSK on the lupus drug Benlysta, which won regulatory approval in the United States and Europe last year small personal loans. Benlysta accounted for $31.2 million of HGS’ first quarter revenue of $47.1 million.
The two companies are also cooperating in late-stage development of darapladib, for the treatment of cardiovascular disease, and albiglutide, for type 2 diabetes.
“GSK values the long relationship it has with HGS and has clearly stated its preference to complete a transaction on a friendly basis in a timely fashion,” the company said. “GSK remains willing to meet and review its offer with HGS at any time.”
Show off a new gadget to your friends or family and inevitably one person in the group will declare, "Soon they’ll just plug these things directly into your brain!" And everyone will laugh, as if they’ve never heard that joke before.
It’s no joke.
An Intel-commissioned white paper released Wednesday on the future of mobile technology concludes that connected devices interfacing with the human brain is an inevitability.
Here’s how the paper’s authors, from consultancy Booz Allen Hamilton, put it: "As convergence continues across device types, functions, and capabilities, the melding of mobile technologies directly into the human body becomes the logical next step."
They add: "By harnessing the processing power and capabilities of mobile devices, for example, our biological brain will be augmented exponentially by a digital counterpart."
Don’t expect to plug your iPhone directly into your cranium in the next few years. There’s a few remaining steps on the path toward turning us all into cyborgs.
First, "form factors" need to die. If you can do it on your computer at work, you should be able to do the exact same thing on your smartphone, or even your glasses.
Processor speeds need to continue rising, and computers need to improve their natural-language support so we can interact with our devices like we would with another human being. Also, security has to advance so that devices can recognize their owners, eliminating the need for passwords.
It sounds like far-off sci-fi stuff, but all of those evolutions are in the works today.
Microsoft (, Fortune 500) is starting to show progress on its vision of one converged operating system for all devices. IBM (, Fortune 500) is making incredible strides in its Watson technology that can "understand" natural human language. Google’s (, Fortune 500) latest Android phones can recognize their owners’ faces to unlock their devices, and both Google and Microsoft are working on wearable computer displays.
Related story: 5 new looks for your future PC
So that’s step one: a lag-free operating system that anyone can use intuitively to perform any computing task.
Step two: Interfacing with the body. These kinds of interfaces are already operating in a relatively rudimentary way, with implants and pacemakers. But in its paper, Intel suggests that the link-up will be much more robust.
How robust? Well, have you seen The Matrix?
"With thoughts able to be delivered seamlessly to the cloud and data projected in real time onto our vision … our bodies and minds will become the devices with all of the associated benefits," the paper’s authors write.
You’ll literally be "plugged-in" to the cloud, so your brain will have access to all the information on the Internet. You’ll never again forget a name or miss a meeting. You won’t have to get a routine check-up from a doctor, either, since your gadgets will monitor your vital signs and test your blood for you.
Of course, for every wonderful benefit, there’s an equally scary potential consequence.
Think about all the privacy issues we have today with sites like Facebook. Now imagine giving people the capability to record everything they see and hear and immediately post it to the Internet. The human race could turn into something like Star Trek’s Borg, who can access the entire network and literally knew everyone’s thoughts.
Plus, how would exam-taking work? If people begin to rely on their connectedness like a crutch, can it just be turned off or wiped out for security purposes?
We’d better be prepared to answer these questions, because Intel (, Fortune 500) says it’s coming soon, whether we like it or not.
"While the future is never certain, a future where humans are infused with mobile technology where we are part of the device, our own bodies and brains part of the technology, and where there are no barriers to pure capability, is becoming more believable by the day," Intel’s paper concludes.
British Prime Minister David Cameron says he discussed News Corp.’s bid to take full control of a British broadcaster with James Murdoch, but denies promising to support the deal in return for favorable coverage from the media giant’s newspapers.
A judge-led inquiry into media ethics in Britain has raised questions about the government’s links to News Corp., particularly as it deliberated on whether the firm should be authorized to take full control of British Sky Broadcasting, in which it holds a 39 percent stake.
Cameron told BBC television Sunday that had chatted about the takeover bid with James Murdoch at a Christmas party, but insisted he had not brokered any tit-for-tat deal with him or his media mogul father Rupert Murdoch.
Laclede Group Inc., the owner of Missouri’s largest natural gas utility, overcame one of the mildest winters on record to post a higher fiscal second-quarter profit.
Net income for the three months ended March 31 rose 6 percent to $29.7 million, or $1.32 a share, from $27.9 million, or $1.25 a share, for the same period last year, the St. Louis-based company said.
Sales fell more than a third to $358.2 million.
Earnings for the company’s gas utility, Laclede Gas Co totally free credit score., fell slightly to $25.9 million as customers ran their furnaces less because of the warmer winter.
The company’s wholesale natural gas marketing business more than made up the difference, more than doubling its profit to $3.8 million.
Europe may add an annex to its budget treaty spelling out how countries can boost growth as the bloc shifts its emphasis on tackling the debt crisis, a German government official said.
Steps to raise competitiveness along with structural reforms are likely to feature in the prescriptions for growth, with a target date for completion by the June 18-19 Group of 20 leaders
Parts of the Canadian housing market, especially condominiums in some major cities, have seen prices jump to levels that warrant caution, the head of the country
Powered by WordPress -- XHTML 1.0